BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18594527)

  • 21. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement.
    Yoshimoto M; Joshua AM; Chilton-Macneill S; Bayani J; Selvarajah S; Evans AJ; Zielenska M; Squire JA
    Neoplasia; 2006 Jun; 8(6):465-9. PubMed ID: 16820092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma.
    Achcar Rde O; Nikiforova MN; Dacic S; Nicholson AG; Yousem SA
    Hum Pathol; 2009 Jun; 40(6):854-60. PubMed ID: 19269006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Value of Combined Detection of Serum PSA, MALAT1 and TMPRSS2-ETV1 in Evaluating the Progress and Prognosis of Prostate Cancer.
    Zhao G; Pan Z; Wang P
    Arch Esp Urol; 2023 Oct; 76(8):555-562. PubMed ID: 37960954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
    Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
    Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model.
    Rahim S; Minas T; Hong SH; Justvig S; Çelik H; Kont YS; Han J; Kallarakal AT; Kong Y; Rudek MA; Brown ML; Kallakury B; Toretsky JA; Üren A
    PLoS One; 2014; 9(12):e114260. PubMed ID: 25479232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.
    Rouzier C; Haudebourg J; Carpentier X; Valério L; Amiel J; Michiels JF; Pedeutour F
    Cancer Genet Cytogenet; 2008 May; 183(1):21-7. PubMed ID: 18474293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and outcome of pediatric acute lymphoblastic leukemia with ZNF384 gene rearrangements including a novel translocation resulting in an ARID1B/ZNF384 gene fusion.
    Shago M; Abla O; Hitzler J; Weitzman S; Abdelhaleem M
    Pediatr Blood Cancer; 2016 Nov; 63(11):1915-21. PubMed ID: 27392123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases.
    Mehra R; Han B; Tomlins SA; Wang L; Menon A; Wasco MJ; Shen R; Montie JE; Chinnaiyan AM; Shah RB
    Cancer Res; 2007 Sep; 67(17):7991-5. PubMed ID: 17804708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
    Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
    Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion between TMPRSS2 and ETS family members (ERG, ETV1, ETV4) in prostate cancers from northern China.
    Wang JJ; Liu YX; Wang W; Yan W; Zheng YP; Qiao LD; Liu D; Chen S
    Asian Pac J Cancer Prev; 2012; 13(10):4935-8. PubMed ID: 23244085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ETS rearrangements and prostate cancer initiation.
    Carver BS; Tran J; Chen Z; Carracedo-Perez A; Alimonti A; Nardella C; Gopalan A; Scardino PT; Cordon-Cardo C; Gerald W; Pandolfi PP
    Nature; 2009 Feb; 457(7231):E1; discussion E2-3. PubMed ID: 19212347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.
    Eich ML; Chandrashekar DS; Rodriguez Pen A MDC; Robinson AD; Siddiqui J; Daignault-Newton S; Chakravarthi BVSK; Kunju LP; Netto GJ; Varambally S
    Prostate; 2019 Oct; 79(14):1629-1639. PubMed ID: 31376196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 cases.
    Alhamar M; Tudor Vladislav I; Smith SC; Gao Y; Cheng L; Favazza LA; Alani AM; Ittmann MM; Riddle ND; Whiteley LJ; Gupta NS; Carskadon S; Gomez-Gelvez JC; Chitale DA; Palanisamy N; Hes O; Trpkov K; Williamson SR
    Histopathology; 2020 Dec; 77(6):890-899. PubMed ID: 32639612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and characterization of novel fusion genes in prostate cancer by targeted RNA capture and next-generation sequencing.
    Yang J; Chen Y; Lu J; Wang X; Wang L; Liang J; Sun ZS
    Acta Biochim Biophys Sin (Shanghai); 2018 Nov; 50(11):1166-1172. PubMed ID: 30307468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex patterns of ETS gene alteration arise during cancer development in the human prostate.
    Clark J; Attard G; Jhavar S; Flohr P; Reid A; De-Bono J; Eeles R; Scardino P; Cuzick J; Fisher G; Parker MD; Foster CS; Berney D; Kovacs G; Cooper CS
    Oncogene; 2008 Mar; 27(14):1993-2003. PubMed ID: 17922029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.
    Chen BF; Chen ML; Liang DC; Huang YW; Liu HC; Chen SH
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Feb; 62(2):86-91. PubMed ID: 10063718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions.
    Cerveira N; Ribeiro FR; Peixoto A; Costa V; Henrique R; Jerónimo C; Teixeira MR
    Neoplasia; 2006 Oct; 8(10):826-32. PubMed ID: 17032499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells.
    Mao X; Shaw G; James SY; Purkis P; Kudahetti SC; Tsigani T; Kia S; Young BD; Oliver RT; Berney D; Prowse DM; Lu YJ
    Asian J Androl; 2008 May; 10(3):467-73. PubMed ID: 18385909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
    Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel PTPRZ1-ETV1 fusion in gliomas.
    Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
    Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.